How physiologically based pharmacokinetic models should be improved for drug development

被引：1
|
作者：
Hempel, Georg [1 ]
机构：
[1] Westfal Wilheims Univ Munster, Inst Pharmazeut & Med Chem, Klin Pharm, Corrensstr 48, D-48149 Munster, Germany
来源：
FUTURE MEDICINAL CHEMISTRY | 2020年 / 12卷 / 12期
关键词：
antimicrobial drugs; drug development; drug metabolism; infectious disease therapeutics; pharmacokinetics/pharmacodynamics; pharmacology; systems biology; A-PRIORI; KINETICS;
D O I：
10.4155/fmc-2020-0074
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1107 / 1109
页数：3
相关论文
共 50 条
  • [21] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Methaneethorn, Janthima
    Poomsaidorn, Chomkanang
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 495 - 511
  • [22] Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects
    Cui, Cheng
    Sia, Jie En Valerie
    Tu, Siqi
    Li, Xiaobei
    Dong, Zhongqi
    Yu, Zhiheng
    Yao, Xueting
    Hatley, Oliver
    Li, Haiyan
    Liu, Dongyang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (07) : 2711 - 2722
  • [23] Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammation
    Tao, Gabriel
    Chityala, Pavan Kumar
    Li, Li
    Lin, Zhoumeng
    Ghose, Romi
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 360
  • [24] After 50 Years of Hepatic Clearance Models, Where Should We Go from Here? Improvements and Implications for Physiologically Based Pharmacokinetic ModelingS
    Pang, K. Sandy
    Lu, Weijia Ivy
    Mulder, Gerard J.
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (08) : 919 - 931
  • [25] Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues
    Chen, A.
    Yarmush, M. L.
    Maguire, T.
    CURRENT DRUG METABOLISM, 2012, 13 (06) : 863 - 880
  • [26] Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
    Liu, Xiaomei, I
    Momper, Jeremiah D.
    Rakhmanina, Natella
    van den Anker, John N.
    Green, Dionna J.
    Burckart, Gilbert J.
    Best, Brookie M.
    Mirochnick, Mark
    Capparelli, Edmund, V
    Dallmann, Andre
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (02): : 240 - 255
  • [27] Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models
    Qian, Yuli
    Markowitz, John S.
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (07) : 968 - 979
  • [28] The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development
    Yu, Xiang-Qing
    Wilson, Alan G. E.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (06) : 923 - 928
  • [29] Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron
    Lin, Jian
    Goosen, Theunis C.
    Tse, Susanna
    Yamagami, Hidetomi
    Malhotra, Bimal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (11): : 1505 - 1518
  • [30] A Physiologically Based Pharmacokinetic Model of Rifampin in Mice
    Lyons, Michael A.
    Reisfeld, Brad
    Yang, Raymond S. H.
    Lenaerts, Anne J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1763 - 1771
12345